Northlane Capital Partners Invests in United States Drug Testing Laboratories

DES PLAINES, Ill.--(BUSINESS WIRE)--Northlane Capital Partners (“NCP”) announced today that it has invested in United States Drug Testing Laboratories Inc. (“USDTL”), a forensic toxicology laboratory testing for alcohol and substance use. NCP invested alongside USDTL’s management team and its founders, Veronica and Doug Lewis.

USDTL is headquartered in Des Plaines, IL, and offers a broad suite of forensic testing capabilities. The company primarily serves hospitals, health systems, court systems, and employers. USDTL has more than 160 employees and over 1,000 customers in the U.S. and internationally. Additional information is available at https://www.usdtl.com/.

Veronica Lewis, Founder of USDTL, noted, “This is a major milestone for USDTL. Having spent three decades building this platform, we are excited to welcome NCP as our first institutional partner.” She added, “NCP’s deep expertise and experience in the lab services space was highly evident throughout their due diligence process, and we’re excited to continue our investment in the business alongside them.”

Justin DuFour, Partner at NCP, said, “For more than 30 years, USDTL has been an innovative leader in specialized forensic testing in the U.S. We are thrilled to be partnering with another founder-owned company and are well-positioned to support the company’s continued expansion. We plan to leverage our network and experience as we implement value creation initiatives and expand USDTL’s niche testing capabilities.”

USDTL has also appointed Albert Berger as Chief Executive Officer to lead the next phase of the company's expansion. Mr. Berger brings over 20 years of experience in forensic toxicology and laboratory services, having previously served as CEO of Confirm Biosciences and, prior to that, as CEO of Redwood Toxicology. Mr. Berger added, “I am honored to join the USDTL team and am extremely excited to contribute to the company’s growth during this next chapter alongside NCP.”

About Northlane Capital Partners

Based in Bethesda, MD, NCP is a middle-market private equity firm focused on key segments within the healthcare and business services sectors, where its principals have invested more than $1.7 billion of equity capital. NCP’s strategy is to partner with industry-leading companies and great management teams, aligning incentives to accelerate growth and build value. For more information, please visit www.northlanecapital.com.